Tags : Iovance

Insights+: Key Events of ASCO 2020 Virtual Annual Meeting #ASCO20

The American Society of Clinical Oncology (ASCO) is a platform for cancer experts to share views on the latest advancements and new approaches in cancer research and was held virtually this year due to the COVID-19 pandemic. The program features over 250 virtual oral abstract presentations and virtual 2,500 poster presentations in 24 disease-based and […]Read More

Iovance Signs a License Agreement with Novartis to Develop and

Shots: Novartis to receive up front, milestones on the initiation of dosing in different phases of clinical development and approval of the IOV-3001 in the US, EU, and Japan along with royalties on sales of the product Iovance to get right to develop & commercialize Novartis’ IOV-3001 and will focus on GMP manufacturing of IOV-3001 […]Read More